PENTAX & FUJIFILM Renew Alliance to Cement EUS Market Leadership

TOKYO, JAPAN – June 04, 2026 – In a significant strategic move that underscores the competitive dynamics of the medical technology sector, PENTAX Medical and FUJIFILM Corporation have announced the renewal of their long-standing collaboration in the field of Endoscopic Ultrasound (EUS). Effective April 2026, the agreement reinforces the cooperative relationship for the supply of FUJIFILM's advanced ultrasound diagnostic equipment, solidifying a partnership poised to influence the market for years to come.

This renewal is more than a simple supply chain agreement; it's a strategic fortification. By ensuring the continued integration of FUJIFILM's ARIETTA™ ultrasound scanners with PENTAX Medical's echoendoscopes, the two companies are cementing their combined position in a rapidly growing and technologically demanding market. The deal's most striking feature—a commitment to provide product support for over a decade—sends a powerful message of stability and long-term value to healthcare providers worldwide.

A Strategic Alliance in a Booming Market

The timing of this renewed pact is critical. The global Endoscopic Ultrasound market is experiencing robust growth, driven by an increasing prevalence of gastrointestinal cancers, a rising demand for minimally invasive diagnostics, and continuous technological innovation. Valued at approximately $1.28 billion in 2023, the market is projected to exceed $1.9 billion by 2029, expanding at a compound annual growth rate (CAGR) of over 7%. Some forecasts are even more bullish, predicting the market could approach $3.3 billion by 2034.

This expansion has created a fiercely competitive landscape dominated by a handful of key players, including Olympus Corporation and Boston Scientific. In this environment, strategic alliances are not just advantageous; they are essential for survival and growth. The PENTAX-FUJIFILM collaboration exemplifies this trend, leveraging the core competencies of two industry giants. PENTAX Medical brings its deep expertise in flexible, reusable endoscopy, while FUJIFILM contributes its renowned prowess in advanced diagnostic imaging.

By continuing their partnership, the companies can offer a seamlessly integrated, market-leading solution that is more than the sum of its parts. This synergy allows them to compete more effectively against rivals that offer a full suite of proprietary EUS components, providing a compelling alternative for hospitals and clinics seeking best-in-class technology from specialized leaders.

The Integrated Power of Endoscopy and Ultrasound

At the heart of the collaboration is a powerful combination of technologies designed to enhance clinical precision and improve patient outcomes. The agreement covers FUJIFILM's ARIETTA™ 850, ARIETTA™ 750, and ARIETTA™ 65 ultrasound scanners. These systems are paired with PENTAX Medical's EUS-J10 and EB-J10 line of echoendoscopes, all integrated through the INSPIRA™ video processor.

The clinical benefit of this tight integration is profound. EUS procedures require the delicate navigation of an endoscope to place an ultrasound transducer close to internal organs, providing high-resolution images that are unattainable with external ultrasound. The clarity of these images is paramount for diagnosing and staging cancers of the pancreas, esophagus, and lungs, as well as for guiding minimally invasive therapeutic procedures like fine-needle aspiration (FNA) and biopsy (FNB).

FUJIFILM's ARIETTA systems are known for their exceptional image quality, which, when combined with the maneuverability and ergonomic design of PENTAX echoendoscopes, provides physicians with unparalleled visualization. This allows for more accurate characterization of lesions, better delineation of tumor margins, and safer navigation around critical vascular structures. The result is not only enhanced diagnostic accuracy but also a reduction in procedural risks and an expansion of therapeutic possibilities.

"We are excited to continue this long-term relationship, which allows PENTAX Medical to continue providing our valued customers with a world-class clinical experience," said Dominique Vincent, Global President of PENTAX Medical. "Our echoendoscopes are uniquely calibrated to work seamlessly with the ARIETTA ultrasound systems, and this agreement enables us to continue delivering integrated solutions that physicians trust—today and well into the future."

A Decade of Assurance: Redefining Customer Value

Perhaps the most significant aspect of the renewed agreement is the pledge to ensure product support for over a decade. In an industry where capital equipment represents a major investment for healthcare institutions, this commitment offers unprecedented long-term value and investment protection.

Hospital administrators and procurement officers face constant pressure to manage costs while ensuring access to state-of-the-art medical technology. The long lifecycles of devices like EUS systems mean that support, maintenance, and the availability of spare parts are critical considerations. A decade-long support guarantee directly addresses these concerns, reducing the total cost of ownership and mitigating the risk of premature obsolescence.

This commitment goes beyond standard industry practice and aligns with the stringent spirit of regulatory frameworks like the FDA's post-market surveillance requirements and the EU's Medical Device Regulation (MDR). By guaranteeing long-term reliability and support, PENTAX Medical and FUJIFILM are not only building customer trust but also demonstrating a profound commitment to patient safety and sustained clinical performance. For clinicians on the front lines, this means the confidence to build their practice around a stable and dependable platform, ensuring continuity of care for years to come. This strategic assurance is a powerful differentiator in a market where long-term reliability is just as important as initial performance.